07:00 , Jul 9, 2012 |  BC Week In Review  |  Clinical News

COBAS TaqMan HIV-1 Test v2 regulatory update

Roche said FDA approved its COBAS TaqMan HIV-1 Test v2.0 to monitor HIV-1 viral loads in patients. Roche said the test, which has CE Mark approval in Europe, will be available in the U.S. later...
07:00 , May 30, 2011 |  BC Week In Review  |  Clinical News

COBAS TaqMan HIV-1 Test v2 regulatory update

Roche received CE Mark approval for its COBAS TaqMan HIV-1 Test v2.0 for use in smaller laboratories to monitor HIV-1 viral loads in patients. The in vitro PCR test uses the High Pure System Viral...
07:00 , Jun 14, 2010 |  BC Week In Review  |  Clinical News

Cobas AmpliPrep/Cobas TaqMan HIV-1 Test v2 regulatory update

FDA granted market clearance to Roche's Roche Molecular Diagnostics unit for its COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0 to quantify viral load in HIV patients. The dual-PCR target HIV-1 viral load test amplifies and detects...
08:00 , Dec 22, 2008 |  BC Week In Review  |  Clinical News

Cobas AmpliPrep/Cobas TaqMan HIV Test v2 regulatory update

Roche received CE Mark approval for its Cobas AmpliPrep/Cobas TaqMan HIV-1 Test v2.0 for the quantitative detection of HIV-1 RNA from patient blood samples. The real-time PCR test, which can be used to assess patient...